Member Login
  1. Stocks
    2. /
  2. Aptose Biosciences Inc. (TSX: APS)
    3. /

TSX:APS (Aptose Biosciences Inc.)

About APS

Aptose Biosciences Inc. is a clinical-stage biotechnology company committed to developing precision medicines addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Aptose Biosciences Inc. (TSX: APS) Latest News

    Investing

    Is it Time to Buy the TSX’s 3 Worst-Performing Canadian Stocks?

    | Ambrose O'Callaghan

    Canadian stocks like Yellow Pages Limited (TSX:Y) have been throttled over the past year, but investors shouldn’t necessarily look past…

    Read more »

    Investing

    Aptose Biosciences Climbs 17% to Reclaim Some Losses

    | Amy Legate-Wolfe

    Aptose Biosciences (TSX:APS)(NASDAQ:APTO) recovered 17% after losing 45% this week from results of its drug trial gave investors a wait-and-see…

    Read more »

    Investing

    Why Aptose Biosciences Plunged 45% Yesterday

    | Amy Legate-Wolfe

    Aptose Biosciences (TSX:APT)(NASDAQ:APTO) results for its leukemia drug were met with a poor reaction, sending shares down 45%.

    Read more »

    Coronavirus

    3 TSX Stocks Bay Street Expects Could Double or Triple in 1 Year!

    | Amy Legate-Wolfe

    There are lots of TSX stocks out there that continue to be a deal, but these three offer the best…

    Read more »

    Dividend Stocks

    5 Top TSX Stocks to Buy Amid a Market Rally in April 2021

    | Jitendra Parashar

    Investors can buy these five rallying stocks in April 2021 to benefit from the ongoing market rally.

    Read more »

    Investing

    ACT NOW: 1 Pharma Stock That Could Triple in Value

    | Nikhil Kumar

    Aptose Biosciences Inc. (TSX:APS) is a science-driven biotechnology company producing medicines to cure cancer. The company's shares could rise significantly…

    Read more »

    Coronavirus

    1 Potentially Life-Changing Stock

    | Jed Lloren

    Research suggests that one in two people will be diagnosed with cancer at some point in their lives. This company…

    Read more »

    Dividend Stocks

    Market Crash Lessons: 3 Stocks That Show Cash Is King

    | Adam Othman

    Holding on to cash is a necessity for almost all businesses. Not all companies do, and it's a mistake, which…

    Read more »

    Investing

    Fear a Recession in 2020? Buy This Cheap Biotech Stock

    | Nikhil Kumar

    If Aptose Biosciences Inc (TSX:APS) is successful at treating life-threatening cancers, the stock could see a huge increase in value,…

    Read more »